BCM
BML Capital Management’s Athira Pharma ATHA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $976K | Buy |
3,230,667
+30,000
| +0.9% | +$9.06K | 0.74% | 17 |
|
|
2025
Q1 | $912K | Buy |
3,200,667
+424,782
| +15% | +$121K | 0.74% | 18 |
|
|
2024
Q4 | $1.63M | Buy |
+2,775,885
| New | +$1.63M | 1.01% | 15 |
|
|
2024
Q3 | – | Sell |
-900,000
| Closed | -$2.39M | – | 30 |
|
|
2024
Q2 | $2.39M | Hold |
900,000
| – | – | 1.7% | 11 |
|
|
2024
Q1 | $2.47M | Sell |
900,000
-554,362
| -38% | -$1.52M | 1.63% | 13 |
|
|
2023
Q4 | $3.53M | Sell |
1,454,362
-250,000
| -15% | -$608K | 2.68% | 9 |
|
|
2023
Q3 | $3.44M | Sell |
1,704,362
-160,545
| -9% | -$324K | 3.16% | 9 |
|
|
2023
Q2 | $5.5M | Hold |
1,864,907
| – | – | 4.95% | 8 |
|
|
2023
Q1 | $4.66M | Buy |
1,864,907
+1,150,144
| +161% | +$2.88M | 4.03% | 9 |
|
|
2022
Q4 | $2.27M | Buy |
+714,763
| New | +$2.27M | 2.16% | 13 |
|